Switch to
More onapp

Sandu Pharmaceuticals Ltd

SANDUPHQ
Consumer StaplesFMCG - Personal Products
SmallcapWith a market cap of ₹58 cr, stock is ranked 2,499
Moderate RiskStock is 2.65x as volatile as Nifty
69.001.15 (+1.69%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Consumer StaplesFMCG - Personal Products
SmallcapWith a market cap of ₹58 cr, stock is ranked 2,499
Moderate RiskStock is 2.65x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
36.95
PB RatioPB Ratio
1.60
Dividend YieldDiv. Yield
1.13%
Sector PESector PE
49.24
Sector PBSector PB
9.30
Sector Div YldSctr Div Yld
1.42%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sandu Pharmaceuticals is engaged in manufacturing and marketing of ayurvedic medicine

Financial TrendFinancial statements 

201920202021202249.9948.8258.9565.580.660.721.091.58
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.41%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Cash Dividend 
Ex. DateSep 23, 2022

Final • Div/Share: ₹ 0.75

Cash Dividend 
Ex. DateSep 22, 2021

Final • Div/Share: ₹ 0.5

See all events